Login

Lindsay Partridge Reflects on 25 Years as Brickworks CEO Ahead of Retirement | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Sopheon PLC chief executive Greg Coticchia discusses operations, while Itaconix CEO outlines future growth despite short-term challenges.
00:10:00
SkyWater Technology's unique positioning reduces its exposure to semiconductor cyclicality, according to CEO Thomas Sonderman.
00:10:00
Understanding the Benefits and Considerations of Mechanically Stabilized Earth (MSE) Systems
00:10:00
Maximizing Fleet Efficiency: EROAD & Phillips Connect Partnership Webinar Highlights | David Kenneson, Co-Chief Executive Officer of EROAD Ltd
00:10:00
Florencia Stefani Explores Savings, Inflation, Economic Slowdown, and Pension Reform with Economist Michèle Labbé | LarrainVial Asset Management
00:10:00
The Evolution and Consolidation of Emerging Technologies
00:10:00
A General Guide to IRS Audits | Vince Carson - Tax Specialist at Howe & Rusling
00:10:00
To consistently grow capital through investment|Clive R Holmes,Managing Partner,Silverfern CoInvestment Partners
00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited
00:10:00
Short-term Volatility and Long-term Prospects in Global Markets | Mark Makepeace, CEO , Wilshire Associates.
00:10:00
Limeade’s Focus on Employee Well-Being: Insights from CEO Henry Albrecht | Henry Albrecht, CEO , Limeade Inc.
00:10:00
Brookfield Asset Management's CEO Bruce Flatt discusses infrastructure investing on Bloomberg Wealth with David Rubenstein.

© 2017 - Neuhu+